Founded by leading microbiome experts in 2015, RondinX's cutting-edge technology platform utilizes proprietary algorithms, including the PTR family, to unlock the potential of microbiome therapeutics. The cloud-based computational pipeline integrates raw metagenomics, other omics, and patient metadata to derive both static and dynamic strain level insights into the bacterial ecosystem. RondinX's PTR algorithms provide a comprehensive understanding of the microbiome, enabling the development of solutions in the microbiome therapeutic and companion diagnostic spaces. The technology is exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science.